Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

cannabis use disorder marijuana joint weed smoking

Cannabis is bad for the heart—should the risk be taken more seriously?

Use of the drug more than doubles a person's risk of dying from heart disease, according to a new analysis of 24 different studies. In a separate editorial, two physicians shared their concerns and highlighted the importance of discussing these risks with patients.

merger acquisition M&A business

Eli Lilly to acquire gene-editing specialists focused on CVD for up to $1.3B

The company has agreed to acquire Verve Therapeutics for an upfront payment of approximately $1 billion. The total could increase significantly, however, if certain milestones are met. One of Verve's biggest gene therapies has already received the FDA's fast track designation.

meditation yoga relax

Meditation linked to ‘real, lasting benefits’ for high-risk heart patients

A popular meditation technique may help high-risk patients protect their hearts for up to 10 years, according to a new randomized controlled trial published in Frontiers in Medicine.

milli-spinner thrombectomy designed to target blood clots by engineers with Stanford University

Tiny clot-busting robots could transform care for stroke and heart attack patients

The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.”

Prevail DCB Medtronic

Medtronic drug-coated balloon gains multiple new approvals

The Prevail DCB has been cleared to use in dozens of countries around the globe, but it has not yet been approved by the FDA.

The Shockwave Medical M5+ new peripheral intravascular lithotripsy (IVL) catheter cuts procedures times in half and was showed for the first time at the American College of Cardiology (ACC) 2022 meeting. It is designed to break up calcium in heavily calcified arteries to avoid the need for vessel trauma caused by high pressure angioplasty.

IVL delivers significant value for women, real-world data confirm

Researchers tracked data from nearly 400 women with complex CAD who underwent treatment with Shockwave Medical's intravascular lithotripsy technology prior to PCI.

walk exercise support family

Heart patients, stroke survivors may live longer if they stay active after hospital discharge

Some patients struggle to bounce back after being hospitalized, but too much sedentary behavior could cause their health to get even worse. The research teams behind two separate studies are highlighting the importance of staying active.

robotic PCI Corindus CorPath GRX

Robotic PCI confirmed to be both safe and effective in new comprehensive analysis

Researchers reviewed years of data from two different Corindus systems, highlighting the consistently high clinical and technical success rates.